Skip to main content
Clinical Trials/ACTRN12614000619640
ACTRN12614000619640
Recruiting
Phase 2

A double blind randomized clinical trial to evaluate the effect of oral memantine on the prevention of post ECT cognition disorders

Mohammad Abbasinazari0 sites40 target enrollmentJune 11, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Post ECT cognition disorders
Sponsor
Mohammad Abbasinazari
Enrollment
40
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mohammad Abbasinazari

Eligibility Criteria

Inclusion Criteria

  • All patients between 18\-60 years old undergoing ECT in the psychosomatic ward of Taleghani hospital(Tehran, Iran) with informed consent

Exclusion Criteria

  • patients with renal failure or hepatic failure, those with cardiac block, patients using medications with anticholinergic or NMDA(N\-methyl D aspartate) antagonistic effect,pregnant and brearstfeeding women

Outcomes

Primary Outcomes

Not specified

Similar Trials